Graft-versus-host disease: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 5: Line 5:


{{SK}} GVHD
{{SK}} GVHD
==[[Graft-versus-host disease patient information|Patient Information]]==


==[[Graft-versus-host disease overview|Overview]]==
==[[Graft-versus-host disease overview|Overview]]==
Line 27: Line 29:


==Diagnosis==
==Diagnosis==
 
[[Graft-versus-host disease diagnostic study of choice|Diagnostic Study of Choice]]
[[Graft-versus-host disease history and symptoms|History and Symptoms]]
| [[Graft-versus-host disease history and symptoms|History and Symptoms]]
| [[Graft-versus-host disease physical examination|Physical Examination]]
| [[Graft-versus-host disease physical examination|Physical Examination]]
| [[Graft-versus-host disease laboratory findings|Laboratory Findings]]
| [[Graft-versus-host disease laboratory findings|Laboratory Findings]]
| [[Graft-versus-host disease electrocardiogram|Electrocardiogram]]
| [[Graft-versus-host disease chest x ray|Chest X Ray]]
| [[Graft-versus-host disease chest x ray|Chest X Ray]]
| [[Graft-versus-host disease echocardiograph and ultrasound|Echocardiograph and Ultrasound]]
| [[Graft-versus-host disease CT|CT]]
| [[Graft-versus-host disease CT|CT]]
| [[Graft-versus-host disease mri|MRI]]
| [[Graft-versus-host disease other imaging findings|Other Imaging Findings]]
| [[Graft-versus-host disease other imaging findings|Other Imaging Findings]]
| [[Graft-versus-host disease other diagnostic studies|Other Diagnostic Studies]]
| [[Graft-versus-host disease other diagnostic studies|Other Diagnostic Studies]]
Line 38: Line 43:
==Treatment==
==Treatment==
| [[Graft-versus-host disease medical therapy|Medical Therapy]]
| [[Graft-versus-host disease medical therapy|Medical Therapy]]
| [[Graft-versus-host disease surgery|Surgery]]
| [[Graft-versus-host disease primary prevention|Primary Prevention]]
| [[Graft-versus-host disease primary prevention|Primary Prevention]]
| [[Graft-versus-host disease secondary prevention|Secondary Prevention]]
| [[Graft-versus-host disease secondary prevention|Secondary Prevention]]

Revision as of 19:03, 2 August 2018

Graft-versus-host disease

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Graft-versus-host disease from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

Echocardiograph and Ultrasound

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Graft-versus-host disease On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Graft-versus-host disease

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Graft-versus-host disease

CDC on Graft-versus-host disease

Graft-versus-host disease in the news

Blogs on Graft-versus-host disease

Directions to Hospitals Treating Type page name here

Risk calculators and risk factors for Graft-versus-host disease

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Shyam Patel [2]

Synonyms and keywords: GVHD

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Graft-versus-host disease from Other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice | History and Symptoms | Physical Examination | Laboratory Findings | Electrocardiogram | Chest X Ray | Echocardiograph and Ultrasound | CT | MRI | Other Imaging Findings | Other Diagnostic Studies

Treatment

| Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies

Case Studies

Case #1

Related Chapters